Consistently, the FXR expression was significantly increased in non-small cell lung cancer (NSCLC), which stimulated tumor growth through the direct transactivation of the cyclin D1 (CCND1) gene [108]. The gene discussed is NR1H4; the disease is non-small cell lung carcinoma.